169 related articles for article (PubMed ID: 8335312)
1. Effectiveness of norfloxacin and ofloxacin for treatment of gonorrhoea and decrease of in vitro susceptibility to quinolones over time in Rwanda.
Bogaerts J; Tello WM; Akingeneye J; Mukantabana V; Van Dyck E; Piot P
Genitourin Med; 1993 Jun; 69(3):196-200. PubMed ID: 8335312
[TBL] [Abstract][Full Text] [Related]
2. Auxotypes, serovars, and trends of antimicrobial resistance of Neisseria gonorrhoeae in Kigali, Rwanda (1985-93).
Bogaerts J; Van Dyck E; Mukantabana B; Munyabikali JP; Martinez Tello W
Sex Transm Infect; 1998 Jun; 74(3):205-9. PubMed ID: 9849557
[TBL] [Abstract][Full Text] [Related]
3. Susceptibility pattern of Neisseria gonorrhoeae to antimicrobial agents in Dar es Salaam.
Mbwana J; Mhalu F; Mwakagile D; Masesa J; Moshiro C; Sandstrom E
East Afr Med J; 1999 Jun; 76(6):330-4. PubMed ID: 10750520
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial susceptibilities of Neisseria gonorrhoeae in Kigali, Rwanda, and trends of resistance between 1986 and 2000.
Van Dyck E; Karita E; Abdellati S; Dirk VH; Ngabonziza M; Lafort Y; Laga M
Sex Transm Dis; 2001 Sep; 28(9):539-45. PubMed ID: 11518873
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial susceptibility and plasmid profile of Neisseria gonorrhoeae in India (New Delhi).
Bhalla P; Sethi K; Reddy BS; Mathur MD
Sex Transm Infect; 1998 Jun; 74(3):210-2. PubMed ID: 9849558
[TBL] [Abstract][Full Text] [Related]
6. Plasmid patterns and antimicrobial susceptibilities of Neisseria gonorrhoeae in Bandung, Indonesia.
Djajakusumah T; Sudigdoadi S; Meheus A; Van Dyck E
Trans R Soc Trop Med Hyg; 1998; 92(1):105-7. PubMed ID: 9692169
[TBL] [Abstract][Full Text] [Related]
7. A one-year survey of Neisseria gonorrhoeae isolated from patients attending an east London genitourinary medicine clinic: antibiotic susceptibility patterns and patients' characteristics.
Lewis DA; Ison CA; Livermore DM; Chen HY; Hooi AY; Wisdom AR
Genitourin Med; 1995 Feb; 71(1):13-7. PubMed ID: 7750947
[TBL] [Abstract][Full Text] [Related]
8. Neisseria gonorrhoeae Antimicrobial Susceptibility Surveillance - The Gonococcal Isolate Surveillance Project, 27 Sites, United States, 2014.
Kirkcaldy RD; Harvey A; Papp JR; Del Rio C; Soge OO; Holmes KK; Hook EW; Kubin G; Riedel S; Zenilman J; Pettus K; Sanders T; Sharpe S; Torrone E
MMWR Surveill Summ; 2016 Jul; 65(7):1-19. PubMed ID: 27414503
[TBL] [Abstract][Full Text] [Related]
9. Susceptibility of gonococci isolated in London to therapeutic antibiotics: establishment of a London surveillance programme. London Gonococcal Working Group.
Ison CA; Martin IM
Sex Transm Infect; 1999 Apr; 75(2):107-11. PubMed ID: 10448363
[TBL] [Abstract][Full Text] [Related]
10. In vitro activities of seven quinolone derivatives against Neisseria gonorrhoeae.
van der Willigen AH; Degener JE; Vogel M; Stolz E; Wagenvoort JH
Arzneimittelforschung; 1990 Jun; 40(6):684-5. PubMed ID: 2118763
[TBL] [Abstract][Full Text] [Related]
11. High prevalence of Neisseria gonorrhoeae strains with reduced susceptibility to fluoroquinolones in Japan.
Tanaka M; Kumazawa J; Matsumoto T; Kobayashi I
Genitourin Med; 1994 Apr; 70(2):90-3. PubMed ID: 8206482
[TBL] [Abstract][Full Text] [Related]
12. Genotypic evolution in a quinolone-resistant Neisseria gonorrhoeae isolate from a patient with clinical failure of levofloxacin treatment.
Tanaka M; Sagiyama K; Haraoka M; Saika T; Kobayashi I; Naito S
Urol Int; 1999; 62(1):64-8. PubMed ID: 10436438
[TBL] [Abstract][Full Text] [Related]
13. In vitro antimicrobial sensitivity of Neisseria gonorrhoeae from Rwanda.
Bogaerts J; Vandepitte J; Van Dyck E; Vanhoof R; Dekegel M; Piot P
Genitourin Med; 1986 Aug; 62(4):217-20. PubMed ID: 2942456
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial resistance in gonococci isolated from patients and from commercial sex workers in Harare, Zimbabwe.
Mason PR; Gwanzura L; Latif AS; Marowa E; Ray S; Katzenstein DA
Int J Antimicrob Agents; 1997 Jan; 9(3):175-9. PubMed ID: 9552714
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial susceptibility and types of Neisseria gonorrhoeae in Greece. Data for the period 1990 to 1993.
Tzelepi E; Avgerinou H; Kyriakis KP; Tzouvelekis LS; Flemetakis A; Kalogeropoulou A; Frangouli E
Sex Transm Dis; 1997 Jul; 24(6):378-85. PubMed ID: 9243747
[TBL] [Abstract][Full Text] [Related]
16. Single dose oral norfloxacin or intramuscular spectinomycin to treat gonorrhoea (PPNG and non-PPNG infections): analysis of efficacy and patient preference.
Panikabutra K; Lee CT; Ho B; Bamberg P
Genitourin Med; 1988 Aug; 64(4):235-40. PubMed ID: 2971603
[TBL] [Abstract][Full Text] [Related]
17. Rapid decline in penicillinase-producing Neisseria gonorrhoeae in Hong Kong associated with emerging 4-fluoroquinolone resistance.
Kam KM; Lo KK; Ho NK; Cheung MM
Genitourin Med; 1995 Jun; 71(3):141-4. PubMed ID: 7635487
[TBL] [Abstract][Full Text] [Related]
18. Epidemic spread of plasmid-mediated tetracycline resistant Neisseria gonorrhoeae in Zaire.
Van Dyck E; Laga M; Manoka AT; Behets F; Piot P
Int J STD AIDS; 1995; 6(5):345-7. PubMed ID: 8547415
[TBL] [Abstract][Full Text] [Related]
19. Rising quinolone resistance in Neisseria gonorrhoeae isolates from New Delhi.
Bhalla P; Vidhani S; Reddy BS; Chowdhry S; Mathur MD
Indian J Med Res; 2002 Mar; 115():113-7. PubMed ID: 12201175
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial susceptibility of Neisseria gonorrhoeae isolates from symptomatic men attending the Nanjing sexually transmitted diseases clinic (2011-2012): genetic characteristics of isolates with reduced sensitivity to ceftriaxone.
Li S; Su XH; Le WJ; Jiang FX; Wang BX; Rice PA
BMC Infect Dis; 2014 Nov; 14():622. PubMed ID: 25427572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
